Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Fellows are established scholars with proven research excellence in data science, artificial intelligence (AI), or a related field.

In the centre we see a photo of a man. In the background there is a network-like illustration.

Dr Hashem Koohy, Associate Professor of Systems Immunology and head of the Machine Learning and Integrative Approaches in Immunology Group based in both the Centre for Computational Biology and the MRC Human Immunology Unit, is one of 33 researchers from the University of Oxford to be named as an Alan Turing Institute Fellow for the 2021-22 academic year.

The Alan Turing Institute is the UK’s national institute for data science and AI, with research spanning the theoretical foundations of data science, ethical issues, as well as cutting-edge applications of data and AI.

Read the full story on the Oxford University website.

Similar stories

Join us at the IF Science and Ideas Festival

Come down to Templars Shopping Centre on 23rd or 24th October 2021 for ‘Science at the Shops’ as part of IF Oxford Science and Ideas Festival.

Changes in blood cell production over the human lifetime may hold clues to patterns of disease

A new paper published in Cell Reports reveals that changes in the gene expression of blood stem cells occur across the human lifetime; an important step in the understanding and treatment of blood disorders.

New Associate Professor appointments announced

Congratulations to Dr Bethan Psaila, Dr Benjamin Fairfax, Dr Hashem Koohy, Dr Andrew Blackford and Dr Oliver Bannard who have all been awarded the title of Associate Professor in recognition of their research achievements, contribution to teaching and contributions to the Medical Sciences Division.

Mechanism behind repair of cancer-inducing mutations discovered

New Nature paper uncovers the precise mechanism behind how the BRCA1 protein detects and engages with DNA breaks in the genome, helping to prevent the development of breast and ovarian cancers.